Literature DB >> 27300444

Hydrogen peroxide prevents vascular calcification induced ROS production by regulating Nrf-2 pathway.

Wensong Zhang1, Yi Li1, Hanlu Ding1, Yaqin Du1, Li Wang1.   

Abstract

BACKGROUND: Although vascular calcification in end-stage renal disease (ESRD) represents a ubiquitous human health problem, effective therapies with limited side effects are still lacking, and the precise mechanisms are not fully understood. The Nrf-2/ARE pathway is a pivotal to regulate anti-oxidative responses in vascular calcification upon ESRD. Although Nrf-2 plays a crucial role in atherosclerosis, pulmonary fibrosis, and brain ischemia, the effect of Nrf-2 and oxidative stress on vascular calcification in ESRD patients is still unclear. The aim of this research was to study the protective role of hydrogen peroxide in vascular calcification and the mechanism of Nrf-2 and oxidative stress on vascular calcification.
MATERIALS AND METHODS: Here we used the rat vascular smooth muscle cell model of β-glycerophosphate-induced calcification resembling vascular calcification in ESRD to investigate the therapeutic effect of 0.01 mM hydrogen peroxide on vascular calcification and further explores the possible underlying mechanisms.
RESULTS: Our current report shows the in vitro role of 0.01 mM hydrogen peroxide in protecting against intracellular ROS accumulation upon vascular calcification. Both hydrogen peroxide and sulforaphane pretreatment reduced ROS production, increased the expression of Nrf-2, and decreased the expression of Runx2 following calcification.
CONCLUSION: Our study demonstrates that 0.01 mM hydrogen peroxide can effectively protect rat aortic vascular smooth muscle cells against oxidative stress by preventing vascular calcification induced ROS production through Nrf-2 pathway. These data might define an antioxidant role of hydrogen peroxide in vascular calcification upon ESRD.

Entities:  

Keywords:  ESRD; Nrf-2; hydrogen peroxide; oxidative stress; vascular calcification

Mesh:

Substances:

Year:  2016        PMID: 27300444     DOI: 10.1080/0886022X.2016.1194143

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  6 in total

Review 1.  Food as medicine: targeting the uraemic phenotype in chronic kidney disease.

Authors:  Denise Mafra; Natalia A Borges; Bengt Lindholm; Paul G Shiels; Pieter Evenepoel; Peter Stenvinkel
Journal:  Nat Rev Nephrol       Date:  2020-09-22       Impact factor: 28.314

2.  Vascular Calcification in Chronic Kidney Disease: An Update and Perspective.

Authors:  Si-Chong Ren; Nan Mao; Si Yi; Xin Ma; Jia-Qiong Zou; Xiaoqiang Tang; Jun-Ming Fan
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

3.  Ubiquitin-specific protease 47 is associated with vascular calcification in chronic kidney disease by regulating osteogenic transdifferentiation of vascular smooth muscle cells.

Authors:  Qiong Xiao; Yun Tang; Juhua Xia; Haojun Luo; Meidie Yu; Sipei Chen; Wei Wang; Lei Pu; Li Wang; Guisen Li; Yi Li
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

Review 4.  Roles of Histone Acetylation Modifiers and Other Epigenetic Regulators in Vascular Calcification.

Authors:  Duk-Hwa Kwon; Juhee Ryu; Young-Kook Kim; Hyun Kook
Journal:  Int J Mol Sci       Date:  2020-05-04       Impact factor: 5.923

Review 5.  Vascular Calcification-New Insights Into Its Mechanism.

Authors:  Sun Joo Lee; In-Kyu Lee; Jae-Han Jeon
Journal:  Int J Mol Sci       Date:  2020-04-13       Impact factor: 5.923

Review 6.  Natural and non-natural antioxidative compounds: potential candidates for treatment of vascular calcification.

Authors:  Chia-Ter Chao; Hsiang-Yuan Yeh; You-Tien Tsai; Pei-Huan Chuang; Tzu-Hang Yuan; Jenq-Wen Huang; Huei-Wen Chen
Journal:  Cell Death Discov       Date:  2019-11-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.